Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 258 results:
Author Title [ Type] Year Filters: Author is Goulis, Dimitrios G [Clear All Filters]
Menopausal hormone therapy for the prevention of cardiovascular disease: Evidence-based customization..
Maturitas. 81(4), 421-2.
(2015). Menopausal hormone therapy for women with obesity in the era of COVID-19..
Case Rep Womens Health. 27, e00233.
(2020). Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease..
Hormones (Athens).
(2022). Menopause and its Cardiometabolic Consequences: Current Perspectives..
Curr Vasc Pharmacol. 17(6), 543-545.
(2019). Menopause and metabolic dysfunction-associated steatotic liver disease..
Maturitas. 108024.
(2024). Menopause in women with multiple sclerosis: A systematic review..
Maturitas. 135, 68-73.
(2020). Menopause symptom management in women with dyslipidemias: An EMAS clinical guide..
Maturitas. 135, 82-88.
(2020). Menopause-associated risk of cardiovascular disease..
Endocr Connect. 11(4),
(2022). MENSTRUAL DISORDERS AND ANDROGEN-RELATED TRAITS IN YOUNG WOMEN WITH TYPE 1 DIABETES MELLITUS: A CLINICAL STUDY..
Endocr Pract.
(2020). Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome..
Hum Reprod Update. 17(6), 741-60.
(2011). Metabolic, Oxidative and Psychological Stress as Mediators of the Effect of COVID-19 on Male Infertility: A Literature Review..
Int J Environ Res Public Health. 19(9),
(2022).
(2019). Moderators of Food Insecurity and Diet Quality in Pairs of Mothers and Their Children..
Children (Basel). 9(4),
(2022). Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?.
Curr Med Res Opin. 30(6), 1177-8.
(2014). New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019). The Niche of n-of-1 Trials in Precision Medicine for Weight Loss and Obesity Treatment: Back to the Future..
Curr Nutr Rep. 11(2), 133-145.
(2022). Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications..
Diabetes Obes Metab. 24(9), 1702-1720.
(2022). Nonalcoholic fatty liver disease and polycystic ovary syndrome..
Ann Hepatol. 14(6), 941-3.
(2015). Nonalcoholic fatty liver disease in males with low testosterone concentrations..
Diabetes Metab Syndr. 14(5), 1571-1577.
(2020).
(2019). Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis..
Hormones (Athens). 13(4), 519-31.
(2014). Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia..
Curr Med Res Opin. 1-10.
(2020). Non-hormonal management of menopausal vasomotor symptoms: Psychosocial interventions..
Maturitas. 82(4), 444-5.
(2015). Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?.
Curr Vasc Pharmacol. 17(6), 573-578.
(2019). Obesity in pregnancy..
Hormones (Athens). 9(4), 299-306.
(2010).